Valuation: Abbott India Limited

Capitalization 73TCr 853.69Cr 727.6Cr 680.11Cr 625.69Cr 1.17TCr 1.31TCr 8.11TCr 3.09TCr 34TCr 3.2TCr 3.14TCr 1,24500Cr P/E ratio 2025
46.2x
P/E ratio 2026 * 47x
Enterprise value 71TCr 823.16Cr 701.58Cr 655.79Cr 603.31Cr 1.12TCr 1.26TCr 7.82TCr 2.98TCr 33TCr 3.09TCr 3.02TCr 1,20100Cr EV / Sales 2025
9.93x
EV / Sales 2026 * 10.1x
Free-Float
24.47%
Yield 2025
1.55%
Yield 2026 * 1.35%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.12%
1 week-0.57%
Current month-3.19%
1 month+8.45%
3 months+17.30%
6 months+16.65%
Current year+15.99%
More quotes
1 week 34,315
Extreme 34315
35,921.55
1 month 30,789.65
Extreme 30789.65
35,921.55
Current year 25,260.2
Extreme 25260.2
35,921.55
1 year 25,260.2
Extreme 25260.2
35,921.55
3 years 17,349.05
Extreme 17349.05
35,921.55
5 years 13,970.1
Extreme 13970.1
35,921.55
10 years 3,953.25
Extreme 3953.25
35,921.55
More quotes
Manager TitleAgeSince
Director of Finance/CFO 51 06/05/2025
Compliance Officer - 14/09/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 82 01/01/1968
Director/Board Member 68 01/03/2011
Director/Board Member - 01/01/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.12%-0.57%+23.69%+77.05% 863.79Cr
-1.00%-0.85%-15.49%+135.67% 70TCr
-0.47%+1.65%+6.00%-13.01% 38TCr
-0.87%+1.08%+12.19%+23.44% 33TCr
-2.24%+0.36%-54.70%+9.61% 32TCr
-1.12%-0.50%+5.67%-20.83% 26TCr
-0.52%+1.50%+1.04%+18.88% 24TCr
-1.14%+0.97%-15.25%-7.14% 22TCr
-0.04%+2.20%-36.02%-13.02% 20TCr
-1.77%+4.92%-5.77%+18.40% 16TCr
Average -0.76%+1.26%-7.87%+22.90% 28.23TCr
Weighted average by Cap. -0.75%+0.89%-11.15%+35.27%
See all sector performances

Financials

2025 2026 *
Net sales 6.46TCr 75Cr 64Cr 60Cr 55Cr 102.85Cr 115.69Cr 715.94Cr 272.92Cr 3.01TCr 282.64Cr 276.81Cr 11TCr 6.99TCr 82Cr 69Cr 65Cr 60Cr 111.25Cr 125.13Cr 774.38Cr 295.2Cr 3.26TCr 305.71Cr 299.41Cr 12TCr
Net income 1.41TCr 16Cr 14Cr 13Cr 12Cr 22Cr 25Cr 156.32Cr 60Cr 658.12Cr 62Cr 60Cr 2.4TCr 1.56TCr 18Cr 15Cr 14Cr 13Cr 25Cr 28Cr 172.61Cr 66Cr 726.71Cr 68Cr 67Cr 2.65TCr
Net Debt -2.62TCr -31Cr -26Cr -24Cr -22Cr -42Cr -47Cr -290.02Cr -110.56Cr -1.22TCr -114.49Cr -112.13Cr -4.45TCr -2.43TCr -28Cr -24Cr -23Cr -21Cr -39Cr -44Cr -269.44Cr -102.71Cr -1.13TCr -106.37Cr -104.18Cr -4.14TCr
More financial data * Estimated data
Logo Abbott India Limited
Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.
Employees
3,814
More about the company
Date Price Change Volume
08/25/08 34,501.00 +0.12% 72
07/25/07 34,459.50 -0.83% 755
04/25/04 34,746.45 -2.07% 399
03/25/03 35,482.40 +0.26% 507
02/25/02 35,389.40 +1.99% 1,082

Delayed Quote Bombay S.E., July 08, 2025 at 09:47 am IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock